Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment

Bello López, José Luis

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/3528

PMID: 23880897

DOI: 10.1097/MNM.0b013e328363c695

ISSN: 0143-3636

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2013

Journal title

NUCLEAR MEDICINE COMMUNICATIONS

Type of content

Artigo